logo

For the Inventor, By the Inventor

Melrose, MA, United States of America

Brett Chevalier

This inventor holds 6 USPTO granted patents and 9 published patent applications. Top assignee: Invetx, Inc.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett Chevalier. Retrieved from https://idiyas.com/inventor/brett-chevalier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal6 out of 9 
 
Invetx, Inc.
 patents

Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12344650 - Compositions for increasing half-life of a therapeutic agent in felines and methods of use (2025-07-01),
2. 11739135 - Compositions for increasing half-life of a therapeutic agent in felines and methods of use (2023-08-29),
3. 11548949 - Compositions for increasing half-life of a therapeutic agent in canines and methods of use (2023-01-10),
4. 11542333 - Compositions for increasing half-life of a therapeutic agent in canines and methods of use (2023-01-03),
5. 11498953 - Compositions for increasing half-life of a therapeutic agent in felines and methods of use (2022-11-15),
6. 11434276 - Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use (2022-09-06),

Title: The Innovations of Brett Chevalier

Introduction

Brett Chevalier is an accomplished inventor based in Melrose, MA (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of therapeutic agents for felines. With a total of 6 patents to his name, Chevalier's work is paving the way for advancements in animal healthcare.

Latest Patents

Among his latest patents are compositions aimed at increasing the half-life of therapeutic agents in felines. These compositions involve variant feline IgG Fc regions, which enhance the effectiveness of polypeptides in treating various conditions in cats. This innovative approach not only improves treatment outcomes but also provides veterinarians with more effective tools for managing feline health.

Career Highlights

Chevalier's career is marked by his dedication to improving veterinary therapeutics. His work at Invetx, Inc. has positioned him as a leader in the field, where he continues to explore new avenues for enhancing the efficacy of treatments for felines. His innovative spirit and commitment to animal welfare are evident in every project he undertakes.

Collaborations

Brett Chevalier collaborates with notable professionals in his field, including William Harold Brondyk and Juergen Horn. These partnerships foster a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in veterinary medicine.

Conclusion

Brett Chevalier's contributions to the field of veterinary therapeutics are noteworthy and impactful. His innovative patents and collaborative efforts are setting new standards in feline healthcare. As he continues to advance his research, the future of veterinary medicine looks promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…